Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN): Pioneering Research In Oncology

Boston, MA 04/22/2014 (wallstreetpr) – Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) focuses largely on cancer research. Innovations and Research The company has witnessed promising preclinical results for RX-21101, its first development candidate obtained from its Nano-Polymer-Drug Conjugate System (NPDCS) platform.  RX-21101 has showed enhanced tumor regression, complete tumor growth inhibition and extended survival in xenograft models. Rexahn Pharmaceuticals […]

Wall Street Breakfast: Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM), Weatherford International Ltd (NYSE:WFT), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN)

Boston, MA 03/04/2014 (wallstreetpr) – Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) which has announced ordering machinery equipment that is worth approximately $17.80 million, will have its executives at the upcoming technology conference in Taiwan. The company announced that it will hold one-on-one meeting sessions with interested investors during the Bank of America Corp. (NYSE:BAC) […]

Shareholder Briefing: BlackBerry Ltd (NASDAQ:BBRY), American Realty Capital Properties Inc (NASDAQ:ARCP), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN)

Boston, MA 03/03/2014 (wallstreetpr) – BlackBerry Ltd (NASDAQ:BBRY) was last seen going down almost 5 percent to $10 in the last trading session. That drop in stock price can cause concern among some investors until they realize that the stock that was once going to the dogs is up 35 percent year to date. BBRY which […]

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) Drops Post Conference

Boston, MA 02/12/2014 (wallstreetpr) – Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN), is a biopharmaceutical engaged in the production of development-stage products. The main line of drugs this company works to bring out are for cross-section of cancers. With one drug candidate on the anvil, the company is considered to hold great potential However, Rexahn Pharmaceuticals, Inc. […]

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) Gave Away Its Gains

Boston, MA 01/15/2013 (wallstreetpr) – After continuously recording a gain for consecutive trading sessions, the shares of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) shed  more than 27% of the gains on Tuesday. The stock closed at $1.16 after loosing 44 cents in value. Soared High On Analysts Note The stock has recorded gains of as much as 150% in […]

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) rises to new 52-week high

Boston, MA 01/14/2013 (wallstreetpr) – The shares of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) touched a 52-week high of $1.85 before closing at $1.60 a rise of more than 40% over the previous close. This mid-cap stock has seen some fantastic gains in the last few trading sessions given the good news about progression of the clinical […]

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN)’s Focus On Cancer Drugs To Pay Off?

Boston, MA 01/13/2013 (wallstreetpr) – Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) is a bio-pharma company engaged in developing, testing and commercializing treatment for cancer and other diseases. The small cap company hit the limelight when it announced that it would be commencing another phase of clinical trials. Rexahn’s Focus Rexahn had a number of products in pipeline, […]